Inflammatory Bowel Diseases Clinical Trial
Official title:
Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
Patients with inflammatory bowel disease, such as Crohn´s disease or ulcerative colitis, have
recurring episodes of abdominal pain, diarrhea and loss of weight. Besides this other
clinical symptoms are possible e.g. deficiency syndromes such as iron deficiency. Iron
deficiency usually attended by symptoms like hair loss, pale skin, loss of concentration or
fatigue. In some cases iron deficiency can lead to neurological manifestations such as
restless-legs-syndrome (RLS). Restless legs syndrome is a neurological disorders which is
accompanied by substantial urge to move legs or other parts of the body and unpleasant
sensations.
Aim of this study is to to investigate the prevalence of RLS in patients with inflammatory
bowel disease and furthermore evaluate the effect of iron supplementation in patients with
iron deficiency and concomitant RLS.
Restless legs syndrome (RLS) is a common neurological disease significantly impacting live
quality. Two recent studies from North America and Japan revealed a surprisingly high
prevalence for RLS in Crohn´s disease and ulcerative colitis (30% and 21%, respectively). The
underlying cause for this high prevalence remains elusive at this point.
To address this gap, a cohort of 353 IBD patients from a tertiary IBD centre was
prospectively evaluated by our IBD team as well as by the colleagues from neurology. IBD
patients (age ≥ 18 years) presenting at our IBD outpatient clinic (tertiary referral center)
between February 2014 and February 2015 were prospectively recruited for the study after
written consent. The study was approved (16 January 2014) by the ethics committee of the
Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (reference EA4/132/13).
Patients were screened for symptoms of iron deficiency (ID) and RLS by a self-developed
questionnaire and explored for RLS symptoms by a gastroenterologist. When at least one
symptom of RLS was present, patients were referred to a neurologist for RLS or differential
diagnosis.
Additionally patients with RLS symptoms were screened for iron-, folic acid- and vitamin
B12-deficiency. If a deficiency was detected, patients were substituted. In patients with
deficiencies, follow-up visits were scheduled at week 4 and 11 after starting
supplementation. Follow-up visits were conducted by the neurologist and the IRLS was
performed in all patients at each visit.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Active, not recruiting |
NCT04989907 -
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Active, not recruiting |
NCT04990258 -
A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
|
||
Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
Enrolling by invitation |
NCT06015789 -
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
|
||
Recruiting |
NCT06065995 -
StoMakker Mobile Application
|
N/A | |
Recruiting |
NCT03282786 -
Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease
|
N/A | |
Recruiting |
NCT06002074 -
SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT04960826 -
Study of an Environmental Risk Factor in Crohn's Disease
|
||
Recruiting |
NCT05413941 -
Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Completed |
NCT00721812 -
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
|
Phase 1 | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Recruiting |
NCT04991324 -
Cholecalciferol Comedication in IBD - the 5C-study
|
Phase 3 | |
Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
Not yet recruiting |
NCT05043818 -
A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
|
||
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT02874365 -
Intestinal Stem Cells Characterization
|
N/A |